Coverage of "Hims" on Cryptosearcher: the stories and the context behind them.
hims stock declined over three sessions amid investor concerns about an imminent FDA review of seven peptides. The upcoming advisory committee meeting could set new rules for compounding pharmacies.
July 23, 2026
